Manifold Bio's mission is to bring the power of multiplexed measurement to engineering life-saving therapeutics. Founded in 2019 by leading biological engineers, the company is headquartered in Boston, Mass. Manifold Bio's platform will allow multiplexed (pooled) tracking and quantification of thousands of unique protein designs, including monoclonal antibodies and other protein therapeutic scaffolds, across a range of complex testing environments.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/10/20 | $5,400,000 | Seed |
Allston Venture Fund Fifty Years GETTYLAB Playground Global  | undisclosed |
| 07/14/22 | $40,000,000 | Series A |
Fifty Years FPV Ventures GETTYLAB Horizons Ventures Playground Global Section 32 Tencent Holdings Triatomic Capital | undisclosed |
